Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
recent articles
ViewsML AI technology joins Dartmouth Health's clinical expertise to create virtual biomarkers that transform pathology diagnostics VANCOUVER, BRITISH COLUMBIA, CANADA, April 8, 2025 /EINPresswire.com/ -- Techbio innovator ViewsML is...
LINKÖPING, Sweden, April 8, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) signs distribution agreement with pathology AI vendor Paige.AI (Paige). The applications from Paige will be...
Paige PanCancer Detect recognized by FDA as a Breakthrough Device intended to assist pathologists in the detection of cancer across multiple tissue and organ types NEW YORK--(BUSINESS WIRE)--Paige, a leader in next-generation AI...
The United States and Canadian Academy of Pathology (USCAP) Annual Meeting is always a standout—a forum for trading the latest insights, engaging with the Concentriq community, and enjoying time with our team. This year’s event was no...
AUSTIN, Texas (March 27, 2025) – Clinical laboratory and pathology executives from many of the nation’s most-prominent clinical labs will come together on April 28-30, 2025 in New Orleans, LA, to celebrate the 30th anniversary the...
Diagnexia and Stratipath: Collaboration expands AI-based risk profiling tools Diagnexia has announced a partnership with Stratipath AB to bring Stratipath Breast, an AI-based prognostic risk profiling tool, to healthcare providers...
